Long-term effectiveness of dopamine agonists and monoamine oxidase B inhibitors compared with levodopa as initial treatment for Parkinson's disease (PD MED): A large, open-label, pragmatic randomised trial, Gray, R., Ives, N., Rick, C., Patel, S., Gray, A., Jenkinson, C., McIntosh, E., Wheatley, K., Williams, A., Young, J., Barrett, J., Johnson, M., Prescott, R., Jones, E., Lewis, S., Davison, J., Gray, C., Bell, J., Lawrence, J., Parry, M., Evans, C., Williams, H., Moseley, L., Simpson, B., Walker, D., Green, M., Lee, M., Hand, A., Robinson, L., Jones, P., Ellis, C., Gray, D., Wilson, M., Jones, A., Martin, A., Thompson, C., James, M., Gordon, C., Wright, A., Adams, J., Franks, S., Cooper, S., Bennett, J., Moore, A., Jones, C., Ward, T., Ashley, S., Baker, K., Buckley, C., Martin, L. 27 Sep 2014, In: The Lancet
